Education
About Us
Working with TipRanks
Follow Us
Goldman Myla Lai Insider Profile
4 Followers
Goldman Myla Lai, Director at West Pharmaceutical Services, holds 18.35K shares in West Pharmaceutical Services (Ticker: WST), holds 20.00K shares in Akoya Biosciences (Ticker: AKYA), holds 79.58K shares in Sequenom (Ticker: SQNM).
Goldman Myla Lai has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Goldman Myla Lai holds in companies
Most Profitable Insider Trade
The most profitable trade made by Goldman Myla Lai
Goldman Myla Lai's Trading History
West Pharmaceutical Services
Apr 25, 2024
Director
Uninformative Buy
―
$4.25M
Akoya Biosciences
Jun 12, 2023
Director
Informative Buy
100.00K
$31.80K
Sequenom
Sep 07, 2016
―
Uninformative Sell
―
$190.19K
Labcorp Holdings
―
EVP & Chief Medical Officer
―
$6.32M
List of latest transactions for each holding click on a transaction to see Goldman Myla Lai's performance on stock
You May Also Like
Goldman Myla Lai insider profile FAQ
What is the percentage of profitable transactions made by Goldman Myla Lai?
The percentage of profitable transactions made by Goldman Myla Lai is ―.
What is the average return per transaction made by Goldman Myla Lai?
The average return per transaction made by Goldman Myla Lai is ―.
What stocks does Goldman Myla Lai hold?
Goldman Myla Lai holds: WST, AKYA, SQNM, LH stocks.
What was Goldman Myla Lai’s latest transaction?
Goldman Myla Lai latest transaction was an Uninformative Buy of ―.
What was Goldman Myla Lai's most profitable transaction?
Goldman Myla Lai’s most profitable transaction was an Informative Buy of AKYA stock on June 12, 2023. The return on the trade was -58.40%.
What is Goldman Myla Lai's role in West Pharmaceutical Services?
Goldman Myla Lai's role in West Pharmaceutical Services is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.